Unitedhealth Group INC

UnitedHealth Group Incorporated announced that senior leaders will discuss the company's strategy, market positions, recent results, and expectations at the Wells Fargo Healthcare Conference.

UnitedHealth Group reported strong second quarter 2026 results, exceeding expectations with revenues of $112.0 billion and earnings per share of $6.04, while also raising its full-year earnings outlook.

UnitedHealth Group shareholders re-elected all nine director nominees and ratified the appointment of Deloitte & Touche LLP at the 2026 Annual Meeting.

UnitedHealth Group announced that senior leadership will participate in an interview at the Bank of America Securities Health Care Conference on May 12, 2026.

UnitedHealth Group reported strong first quarter 2026 results, exceeding expectations with revenue growth and an increased full-year earnings outlook, while also detailing strategic initiatives and acquisitions.

UnitedHealth Group announced the appointment of Dennis Stankiewicz as its new Chief Accounting Officer, effective March 2, 2026, with Tom Roos transitioning to CFO of Optum Insight.

UnitedHealth Group's Q2 2026 results show a significant increase in earnings and operating income, driven by strong performance across its segments, despite slight declines in membership.

UnitedHealth Group reported steady Q1 2026 revenues with a 2% increase, driven by UnitedHealthcare's pricing and Optum Rx growth, though earnings from operations saw a slight dip due to segment performance and strategic investments.

UnitedHealth Group reported a 50% decline in third-quarter operating earnings and a 61% drop in net earnings attributable to common shareholders, primarily due to elevated medical cost trends and Medicare funding reductions.

UnitedHealth Group reports strong Q2 2025 revenue growth driven by Medicare Advantage and Optum Rx, despite elevated medical costs and funding pressures impacting earnings.

UnitedHealth Group's Q1 2025 results show revenue growth driven by UnitedHealthcare and Optum, with earnings impacted by Medicare Advantage funding and elevated care patterns.

UnitedHealth Group's third-quarter results show revenue growth offset by increased medical costs and significant losses from divestitures, alongside ongoing impacts from a major cyberattack.

UnitedHealth Group Incorporated announced a significant decline in 2025 operating earnings, driven by elevated medical costs and substantial restructuring charges, despite overall revenue growth.

UnitedHealth Group's 2024 results reflect revenue growth offset by costs related to the Change Healthcare cyberattack and adjustments in Medicare Advantage funding.

UnitedHealth Group has granted performance-based and restricted stock units to executives, outlining vesting conditions, termination clauses, and restrictive covenants.

Frederick William Mcnabb Iii, a Director of Unitedhealth Group Inc, received 57 shares of common stock on September 22, 2026.

Dennis Andrew Stankiewicz, Chief Accounting Officer of Unitedhealth Group Inc, received 51 shares of common stock on September 22, 2026.

Charles D. Baker, a Director of Unitedhealth Group Inc, received 15 shares of common stock on September 22, 2026.

Timothy Patrick Flynn, a Director of Unitedhealth Group Inc, received 68 shares of common stock on September 22, 2026.

John H Noseworthy, a Director of Unitedhealth Group Inc, received 46 shares of common stock on September 22, 2026.

Scott Gottlieb, a Director of Unitedhealth Group Inc, received 5 shares of common stock on September 22, 2026.

UnitedHealth Group's 2026 proxy statement outlines leadership transitions, governance reforms, and executive compensation adjustments following shareholder feedback.

UnitedHealth Group urges shareholders to support its Say on Pay proposal, addressing concerns raised by ISS regarding the compensation package for incoming CEO Steve Hemsley.

UnitedHealth Group's upcoming annual meeting on June 3, 2024, will address director elections, executive compensation, auditor ratification, and a shareholder proposal on political contributions.

UnitedHealth Group's 2025 proxy statement outlines key proposals for the annual shareholder meeting, including director elections, executive compensation, and ratification of the independent auditor, while emphasizing the company's strategic growth priorities and commitment to improving the health system.

UnitedHealth Group's proxy statement announces the 2024 Annual Meeting of Shareholders and details the matters to be voted on, including the election of directors, executive compensation, and the ratification of the company's auditor.

UnitedHealth Group's 2024 proxy statement outlines key proposals for the annual shareholder meeting, including director elections, executive compensation, and responses to the Change Healthcare cyberattack.

State Street Corporation has updated its beneficial ownership filing for UnitedHealth Group common stock, reporting a 5% stake as of June 30, 2026.

Vanguard Capital Management reports beneficial ownership of 68,122,483 shares, representing 7.5% of UnitedHealth Group's common stock as of March 31, 2026.

The Vanguard Group has amended its Schedule 13G for UnitedHealth Group Inc., reporting zero beneficial ownership following an internal realignment where subsidiaries will now report separately.

The Vanguard Group has filed an amended Schedule 13G, reporting a 10.08% beneficial ownership stake in UnitedHealth Group Inc. as of April 30, 2025.